Cancer Biomarkers Market Players:
- INOVIQ
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Rad Laboratories, Inc.
- Abbott Laboratories
- Becton, Dickinson and Company
- Merck KGaA
- CENTOGENE GmbH
- PerkinElmer Inc.
- Siemens Healthcare GmbH
- F. Hoffmann-La Roche Ltd
- Bristol Myers Squibb Company (BMS)
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of cancer biomarkers is evaluated at USD 38.74 Billion.
The cancer biomarkers market size was valued at USD 38.74 Billion in 2026 and is projected to reach USD 120.32 Billion by the end of 2036, rising at a CAGR of 12.0% during the forecast period, i.e., 2027-2036.
North America cancer biomarkers market will hold over 42.6% share by 2036, driven by rising population, growing research, and increasing affordability of treatments.
Key players in the market include INOVIQ, Bio-Rad Laboratories, Inc., Abbott Laboratories, Becton, Dickinson and Company, Merck KGaA, CENTOGENE GmbH, PerkinElmer Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Bristol Myers Squibb Company (BMS).
